Development of amyloid and tau imaging probes for early diagnosis of dementia
Project/Area Number |
20591432
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Radiation science
|
Research Institution | Tohoku University |
Principal Investigator |
OKAMURA Nobuyuki Tohoku University, 大学院・医学系・研究科, 准教授 (40361076)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2008: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | 認知症 / 神経科学 / 放射線 / 脳神経疾患 / 老化 / PET / アルツハイマー病 / アミロイドβ蛋白 |
Research Abstract |
Noninvasive visualization of amyloid-ss (Ass) and tau deposits in the living brain will contribute to a better understanding of the pathophysiology of Alzheimer's disease (AD). Although in vivo Ass imaging probes for positron emission tomography (PET) are currently available, in vivo tau imaging agent is still unavailable for clinical study. As candidate probes for PET tau imaging, we developed novel compounds named [^<18>F]THK-523 and [^<11>C]THK-951. These two compounds showed high binding affinity and specificity to tau protein and high brain-blood barrier permeability.
|
Report
(4 results)
Research Products
(53 results)
-
[Journal Article] [^<18>F]-THK523, a novel in vivo tau imaging ligand for Alzheimer's disease.2011
Author(s)
Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor A, McLean CA, Cao D, Rigopoulos A, O'Keefe G, Gong S, Adlard PA, Barnham KJ, Rowe CC, Masters CL, Kudo Y, Cappai R, Yanai K, Villemagne VL.
-
Journal Title
Brain 134
Pages: 1089-1100
Related Report
Peer Reviewed
-
-
-
[Journal Article] In vivo detection of prion amyloid plaques using [^<11>C]BF-227 PET.2010
Author(s)
Okamura N, Shiga Y, Furumoto S, Tashiro M, Tsuboi Y, Furukawa K, Yanai K, Iwata R, Arai H, Kudo Y, Itoyama Y, Doh-ura K.
-
Journal Title
Eur J Nucl Med Mol Imaging. 37
Pages: 934-941
Related Report
Peer Reviewed
-
[Journal Article] In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson's disease with ^<18>F-AV-133.2010
Author(s)
Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, Ellis JR, Ackermann U, O'Keefe G, Jones G, Hughes A, Kung HF, Pontecorvo MJ, Skovronsky D, Rowe CC.
-
Journal Title
J Nucl Med. 51
Pages: 223-228
Related Report
Peer Reviewed
-
[Journal Article] Voxel-based analysis of amyloid PET probe [^<11>C]BF-227 uptake in mild cognitive impairment and Alzheimer's disease.2010
Author(s)
Shao H, Okamura N, Sugi K, Furumoto S, Furukawa K, Tashiro M, Iwata R, Matsuda H, Kudo Y, Arai H, Fukuda H, Yanai K.
-
Journal Title
Dement Geriatr Cogn Disord. 30
Pages: 101-111
Related Report
Peer Reviewed
-
[Journal Article] In vivo visualization of α-synuclein deposition by [^<11>C]-BF-227 PET in multiple system atrophy.2010
Author(s)
Kikuchi A, Takeda A, Okamura N, Tashiro M, Hasegawa T, Furumoto S, Kobayashi M, Sugeno N, Baba T, Miki Y, Mori F, Wakabayashi K, Funaki Y, Fukuda H, Arai H, Kudo Y, Yanai K, Itoyama Y.
-
Journal Title
Brain 133
Pages: 1772-1778
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
[Journal Article] Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.2009
Author(s)
Waragai M, Okamura N, Furukawa K, Tashiro M, Furumoto S, Funaki Y, Kato M, Iwata R, Yanai K, Kudo Y, Arai H.
-
Journal Title
J Neurol Sci. 285
Pages: 100-108
Related Report
Peer Reviewed
-
-
-
[Journal Article] Quantitative analysis of donepezil binding to acetylcholinesterase using positron emission tomography and [5-^<11>C-methoxy]donepezil.2009
Author(s)
Hiraoka K, Okamura N, Funaki Y, Watanuki S, Tashiro M, Kato M, Hayashi A, Hosokai Y, Yamasaki H, Fujii T, Mori E, Yanai K, Watabe H.
-
Journal Title
Neuroimage. 46
Pages: 616-623
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving.2008
Author(s)
Tashiro M, Sakurada Y, Mochizuki H, Horikawa E, Maruyama M, Okamura N, Watanuki S, Arai H, Itoh M, Yanai K.
-
Journal Title
Hum Psychopharmacol. 23
Pages: 139-150
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Non-invasive detection of α-synuclein deposits in human brain using [^<11>C]BF227-PET.2009
Author(s)
Okamura N, Kikuchi A, Takeda A, Furumoto S, Furukawa K, Arai H, Fodero-Tavoletti MT, Villemagne VL, Itoyama Y, Yanai K, Kudo Y.
Organizer
2009 International Conference on Alzheimer's Disease (ICAD)
Place of Presentation
Vienna
Year and Date
2009-07-15
Related Report
-
-
-
[Presentation] [^<11>C]BF-227 PET Study in Protein Conformational Diseases.2009
Author(s)
Okamura N, Furumoto S, Tashiro M, Funaki Y, Kikuchi A, Shiga Y, Furukawa K, Arai H, Doh-ura K, Iwata R, Yanai K, Kudo Y.
Organizer
EANM'09 Annual Congress of the European Association of Nuclear Medicine
Place of Presentation
Barcelona
Related Report
-
-
[Presentation] PET imaging of brain amyloid deposits using BF-227 and its derivative.2008
Author(s)
Okamura N, Furumoto S, Furukawa K, Tashiro M, Kato M, Mori M, Iwata R, Yanai K, Arai H, Kudo Y.
Organizer
Alzheimer's Imaging Consortium Pre-conference
Place of Presentation
Chicago, USA
Year and Date
2008-07-26
Related Report
-
-
-
[Presentation] PET imaging of brain amyloid deposits using BF-227 and its derivative.2008
Author(s)
Okamura N, Furumoto S, Furukawa K, Tashiro M, Kato M, Mori M, Iwata R, Yanai K, Arai H, Kudo Y.
Organizer
Alzheimer's Association International Conference on Alzheimer's Disease 2008
Place of Presentation
Chicago, USA
Related Report
-
[Presentation] In vivo imaging of brain amyloid deposits using BF-227 and its derivative.2008
Author(s)
Okamura N, Furumoto S, Tashiro M, Kato M, Funaki Y, Furukawa K, Arai H, Iwata R, Yanai K, Kudo Y.
Organizer
SNM 2008 Annual Meeting
Place of Presentation
New Orleans, USA
Related Report
-